A citation-based method for searching scientific literature

Armando Gabrielli, Enrico V Avvedimento, Thomas Krieg. N Engl J Med 2009
Times Cited: 987







List of co-cited articles
598 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Systemic sclerosis.
Christopher P Denton, Dinesh Khanna. Lancet 2017
697
25

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
Frank van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R Johnson, Murray Baron, Alan Tyndall, Marco Matucci-Cerinic, Raymond P Naden, Thomas A Medsger, Patricia E Carreira,[...]. Ann Rheum Dis 2013
995
21

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.
E C LeRoy, C Black, R Fleischmajer, S Jablonska, T Krieg, T A Medsger, N Rowell, F Wollheim. J Rheumatol 1988
20

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.
Frank van den Hoogen, Dinesh Khanna, Jaap Fransen, Sindhu R Johnson, Murray Baron, Alan Tyndall, Marco Matucci-Cerinic, Raymond P Naden, Thomas A Medsger, Patricia E Carreira,[...]. Arthritis Rheum 2013
18

Systemic sclerosis.
Yannick Allanore, Robert Simms, Oliver Distler, Maria Trojanowska, Janet Pope, Christopher P Denton, John Varga. Nat Rev Dis Primers 2015
324
15

Update of EULAR recommendations for the treatment of systemic sclerosis.
Otylia Kowal-Bielecka, Jaap Fransen, Jerome Avouac, Mike Becker, Agnieszka Kulak, Yannick Allanore, Oliver Distler, Philip Clements, Maurizio Cutolo, Laszlo Czirjak,[...]. Ann Rheum Dis 2017
439
11

Systemic sclerosis: a prototypic multisystem fibrotic disorder.
John Varga, David Abraham. J Clin Invest 2007
786
9



Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
Anthony J Tyndall, Bettina Bannert, Madelon Vonk, Paolo Airò, Franco Cozzi, Patricia E Carreira, Dominique Farge Bancel, Yannick Allanore, Ulf Müller-Ladner, Oliver Distler,[...]. Ann Rheum Dis 2010
683
8

Review: evidence that systemic sclerosis is a vascular disease.
Marco Matucci-Cerinic, Bashar Kahaleh, Fredrick M Wigley. Arthritis Rheum 2013
241
8

Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells.
Jun Wei, Feng Fang, Anna P Lam, Jennifer L Sargent, Emily Hamburg, Monique E Hinchcliff, Cara J Gottardi, Radhika Atit, Michael L Whitfield, John Varga. Arthritis Rheum 2012
159
7

Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis.
Lenny van Bon, Alsya J Affandi, Jasper Broen, Romy B Christmann, Renoud J Marijnissen, Lukasz Stawski, Giuseppina A Farina, Giuseppina Stifano, Allison L Mathes, Marta Cossu,[...]. N Engl J Med 2014
243
7

Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma.
T Yamamoto, S Takagawa, I Katayama, K Yamazaki, Y Hamazaki, H Shinkai, K Nishioka. J Invest Dermatol 1999
292
7

Changes in causes of death in systemic sclerosis, 1972-2002.
Virginia D Steen, Thomas A Medsger. Ann Rheum Dis 2007
967
7

Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis.
Dinesh Khanna, Daniel E Furst, Philip J Clements, Yannick Allanore, Murray Baron, Lazlo Czirjak, Oliver Distler, Ivan Foeldvari, Masataka Kuwana, Marco Matucci-Cerinic,[...]. J Scleroderma Relat Disord 2017
167
6

Hypoxia. Hypoxia in the pathogenesis of systemic sclerosis.
Christian Beyer, Georg Schett, Steffen Gay, Oliver Distler, Jörg H W Distler. Arthritis Res Ther 2009
77
7

Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis.
Debomita Chakraborty, Barbora Šumová, Tatjana Mallano, Chih-Wei Chen, Alfiya Distler, Christina Bergmann, Ingo Ludolph, Raymund E Horch, Kolja Gelse, Andreas Ramming,[...]. Nat Commun 2017
151
6

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
Keith M Sullivan, Ellen A Goldmuntz, Lynette Keyes-Elstein, Peter A McSweeney, Ashley Pinckney, Beverly Welch, Maureen D Mayes, Richard A Nash, Leslie J Crofford, Barry Eggleston,[...]. N Engl J Med 2018
228
6

Pathogenesis of Systemic Sclerosis.
Debendra Pattanaik, Monica Brown, Bradley C Postlethwaite, Arnold E Postlethwaite. Front Immunol 2015
191
6

Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis.
Patrizia Fuschiotti, Adriana T Larregina, Johnan Ho, Carol Feghali-Bostwick, Thomas A Medsger. Arthritis Rheum 2013
83
7


Shared and distinct mechanisms of fibrosis.
Jörg H W Distler, Andrea-Hermina Györfi, Meera Ramanujam, Michael L Whitfield, Melanie Königshoff, Robert Lafyatis. Nat Rev Rheumatol 2019
140
6

Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.
Swati Bhattacharyya, Jun Wei, John Varga. Nat Rev Rheumatol 2011
231
6


Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Oliver Distler, Kristin B Highland, Martina Gahlemann, Arata Azuma, Aryeh Fischer, Maureen D Mayes, Ganesh Raghu, Wiebke Sauter, Mannaig Girard, Margarida Alves,[...]. N Engl J Med 2019
461
6

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
Donald P Tashkin, Michael D Roth, Philip J Clements, Daniel E Furst, Dinesh Khanna, Eric C Kleerup, Jonathan Goldin, Edgar Arriola, Elizabeth R Volkmann, Suzanne Kafaja,[...]. Lancet Respir Med 2016
442
6

Autoantibodies are present before the clinical diagnosis of systemic sclerosis.
Peter D Burbelo, Sarah M Gordon, Meryl Waldman, Jess D Edison, Dustin J Little, Rodger S Stitt, Wayne T Bailey, James B Hughes, Stephen W Olson. PLoS One 2019
21
28

The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review.
Y Mostmans, M Cutolo, C Giddelo, S Decuman, K Melsens, H Declercq, E Vandecasteele, F De Keyser, O Distler, J Gutermuth,[...]. Autoimmun Rev 2017
88
6

Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.
P J Clements, P A Lachenbruch, J R Seibold, B Zee, V D Steen, P Brennan, A J Silman, N Allegar, J Varga, M Massa. J Rheumatol 1993
382
6

Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies.
Muriel Elhai, Christophe Meune, Jérôme Avouac, André Kahan, Yannick Allanore. Rheumatology (Oxford) 2012
240
6


The pathogenesis of systemic sclerosis.
Tamiko R Katsumoto, Michael L Whitfield, M Kari Connolly. Annu Rev Pathol 2011
175
6


Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis.
Alfiya Akhmetshina, Katrin Palumbo, Clara Dees, Christina Bergmann, Paulius Venalis, Pawel Zerr, Angelika Horn, Trayana Kireva, Christian Beyer, Jochen Zwerina,[...]. Nat Commun 2012
503
5

The immunopathogenesis of fibrosis in systemic sclerosis.
M Brown, S O'Reilly. Clin Exp Immunol 2019
48
10

Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population.
Maureen D Mayes, James V Lacey, Jennifer Beebe-Dimmer, Brenda W Gillespie, Brenda Cooper, Timothy J Laing, David Schottenfeld. Arthritis Rheum 2003
534
5

Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma.
Sonali Sonnylal, Christopher P Denton, Bing Zheng, Douglas R Keene, Ruming He, Henry P Adams, Carolyn S Vanpelt, Yong J Geng, Jenny M Deng, Richard R Behringer,[...]. Arthritis Rheum 2007
132
5

Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis.
Clara Dees, Michal Tomcik, Pawel Zerr, Alfiya Akhmetshina, Angelika Horn, Katrin Palumbo, Christian Beyer, Jochen Zwerina, Oliver Distler, Georg Schett,[...]. Ann Rheum Dis 2011
92
5

Early T cell activation in the skin from patients with systemic sclerosis.
A Kalogerou, E Gelou, S Mountantonakis, L Settas, E Zafiriou, L Sakkas. Ann Rheum Dis 2005
89
5


Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate).
Dinesh Khanna, Christopher P Denton, Celia J F Lin, Jacob M van Laar, Tracy M Frech, Marina E Anderson, Murray Baron, Lorinda Chung, Gerhard Fierlbeck, Santhanam Lakshminarayanan,[...]. Ann Rheum Dis 2018
145
5

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study.
Muriel Elhai, Marouane Boubaya, Oliver Distler, Vanessa Smith, Marco Matucci-Cerinic, Juan José Alegre Sancho, Marie-Elise Truchetet, Yolanda Braun-Moscovici, Florenzo Iannone, Pavel I Novikov,[...]. Ann Rheum Dis 2019
77
6

Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial.
Geetabali Sircar, Rudra Prosad Goswami, Dipankar Sircar, Alakendu Ghosh, Parasar Ghosh. Rheumatology (Oxford) 2018
87
5

Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.
Jacob M van Laar, Dominique Farge, Jacob K Sont, Kamran Naraghi, Zora Marjanovic, Jérôme Larghero, Annemie J Schuerwegh, Erik W A Marijt, Madelon C Vonk, Anton V Schattenberg,[...]. JAMA 2014
369
5

Type I interferon system activation and association with disease manifestations in systemic sclerosis.
Maija-Leena Eloranta, Karin Franck-Larsson, Tanja Lövgren, Sebastian Kalamajski, Anders Rönnblom, Kristofer Rubin, Gunnar V Alm, Lars Rönnblom. Ann Rheum Dis 2010
116
5

Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis.
Silvia Svegliati Baroni, Mariarosaria Santillo, Federica Bevilacqua, Michele Luchetti, Tatiana Spadoni, Matteo Mancini, Paolo Fraticelli, Paola Sambo, Ada Funaro, Andrius Kazlauskas,[...]. N Engl J Med 2006
402
5

Cyclophosphamide versus placebo in scleroderma lung disease.
Donald P Tashkin, Robert Elashoff, Philip J Clements, Jonathan Goldin, Michael D Roth, Daniel E Furst, Edgar Arriola, Richard Silver, Charlie Strange, Marcy Bolster,[...]. N Engl J Med 2006
966
5

A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease.
Dimitrios Daoussis, Konstantinos Melissaropoulos, Georgios Sakellaropoulos, Ioannis Antonopoulos, Theodora E Markatseli, Theodora Simopoulou, Panagiotis Georgiou, Andrew P Andonopoulos, Alexandros A Drosos, Lazaros Sakkas,[...]. Semin Arthritis Rheum 2017
105
5

Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group.
Suzana Jordan, Jörg H W Distler, Britta Maurer, Dörte Huscher, Jacob M van Laar, Yannick Allanore, Oliver Distler. Ann Rheum Dis 2015
228
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.